$KROS
Keros Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$11.29
▼-0.62%-$0.070
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateKeros Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is KROS up today? It is at $11.29 (+0.00%), and our scanner flagged it 5 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment KROS spikes, and full due diligence on KROS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $KROS 5 times in the last 30 days. Create a free account to track $KROS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on KROS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for KROS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Cho Esther Officer | Sold (automatic/other) | -4K 0.02% of company | sold 11% | 36K | $46K at $10.29 | Aug 18, 26 |
Lerner Lorena Raquel Officer | Sold (automatic/other) | -4K 0.02% of company | sold 11% | 28K | $37K at $10.29 | Aug 18, 26 |
Newton Charles W. Director | Sold (automatic/other) | -551 | sold 4.4% | 12K | $6K at $10.30 | Aug 18, 26 |
Tanini Annita Officer | Sold (automatic/other) | -1K | sold 2.6% | 45K | $13K at $10.29 | Aug 18, 26 |
Bienaime Jean Jacques Director | Acquired (grant/award) | +1K | added 5.4% | 20K | $10K at $10.27 | Aug 17, 26 |
Bienaime Jean Jacques Director | Acquired (grant/award) | +1K | added 5.7% | 19K | $11K at $10.61 | Jul 15, 26 |
Prener Anne Director | Acquired (grant/award) | +14K 0.07% of company | n/a | 14K | n/a | Jul 1, 26 |
Bienaime Jean Jacques Director | Acquired (grant/award) | +1K | added 6.0% | 18K | $10K at $10.19 | Jun 15, 26 |
Newton Charles W. Director | Sold (automatic/other) | -550 | sold 4.2% | 13K | $6K at $10.04 | Jun 11, 26 |
Seth Alpna Director | Sold (automatic/other) | -3K 0.01% of company | sold 21% | 10K | $28K at $10.72 | Jun 4, 26 |
Knowles Julius Director | Sold (automatic/other) | -3K 0.01% of company | sold 19% | 11K | $28K at $10.73 | Jun 4, 26 |
Farzan Nima Director | Sold (automatic/other) | -3K 0.01% of company | sold 21% | 10K | $28K at $10.73 | Jun 4, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on KROS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for KROS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
KROS last traded at $11.29, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Keros Therapeutics, Inc. Common Stock (KROS) is next expected to report earnings on Wednesday, November 4, 2026, about 48 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The KROS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged KROS 5 times in the last 30 days.
KROS (Keros Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $213M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge KROS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$KROS discussion
Sign in to ask a question or join the discussion.